170 related articles for article (PubMed ID: 6673031)
1. [Hemorrheology and neurovascular syndromes of the extremities].
Sergio G; Artale F; Francisci A; Giunti P; Perego MA
Ric Clin Lab; 1983; 13 Suppl 3():481-5. PubMed ID: 6673031
[TBL] [Abstract][Full Text] [Related]
2. Association between capillaroscopy, haemorheological variables and plasma proteins in patients bearing Raynaud's phenomenon.
Spengler MI; Svetaz MJ; Leroux MB; Leiva ML; Bottai HM
Clin Hemorheol Microcirc; 2004; 30(1):17-24. PubMed ID: 14967879
[TBL] [Abstract][Full Text] [Related]
3. [Raynaud's phenomenon and blood viscosity].
Lacombe C; Mouthon JM; Bucherer C; Lelievre JC; Bletry O; Godeau P
J Mal Vasc; 1992; 17 Suppl B():132-5. PubMed ID: 1602250
[TBL] [Abstract][Full Text] [Related]
4. [Blood rheology in Raynaud's disease].
Larcan A; Schmidt C; Stoltz JF; Voisin P
J Mal Vasc; 1984; 9(1):1-6. PubMed ID: 6707529
[TBL] [Abstract][Full Text] [Related]
5. [Raynaud's disease, acrocyanosis and scleroderma in the menopause].
Lo Stumbo F; Banchelli A
Minerva Ginecol; 1965 Nov; 17(21):1034-43. PubMed ID: 5880755
[No Abstract] [Full Text] [Related]
6. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement.
Ayres ML; Jarrett PE; Browse NL
Br J Surg; 1981 Jan; 68(1):51-4. PubMed ID: 7459607
[TBL] [Abstract][Full Text] [Related]
7. [Erythrocyte filterability in Raynaud's disease].
Sciannameo F; Francucci M; Cao PG; Marianeschi P; Valentini M; Tockner M; Sassano L; Grasselli A
Ric Clin Lab; 1983; 13 Suppl 3():475-80. PubMed ID: 6673030
[TBL] [Abstract][Full Text] [Related]
8. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
[TBL] [Abstract][Full Text] [Related]
9. Rheological properties of blood in Raynaud's phenomenon.
Wichers G; Smit AJ; van der Meer J; Wouda AA; Halie MR
Vasa Suppl; 1992; 34():29-33. PubMed ID: 1529415
[TBL] [Abstract][Full Text] [Related]
10. Nomenclature of Raynaud's phenomenon: a capillary microscopic and hemorheologic study.
Jacobs MJ; Breslau PJ; Slaaf DW; Reneman RS; Lemmens JA
Surgery; 1987 Feb; 101(2):136-45. PubMed ID: 3810484
[TBL] [Abstract][Full Text] [Related]
11. Hemorheological factors in Raynaud's phenomenon.
Dintenfass L
Angiology; 1977 Jul; 28(7):472-81. PubMed ID: 900567
[No Abstract] [Full Text] [Related]
12. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
[TBL] [Abstract][Full Text] [Related]
13. Altered microrheological parameters in Raynaud's phenomenon.
Papp J; Sandor B; Toth A; Biro K; Rabai M; Botor D; Kovacs D; Csernus Z; Toth K; Kesmarky G
Clin Hemorheol Microcirc; 2017; 65(1):23-29. PubMed ID: 27258205
[TBL] [Abstract][Full Text] [Related]
14. Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.
Vayá A; Alis R; Romagnoli M; Todolí J; Calvo J; Ricart JM
Clin Hemorheol Microcirc; 2014; 56(3):259-64. PubMed ID: 23609604
[TBL] [Abstract][Full Text] [Related]
15. [Rheology of giant capillary occlusion in secondary Raynaud's phenomenon within the scope of systemic sclerosis].
Schmid-Schönbein H; Goebel W; Perkkiö J; Polster H; Jacobs M; Lemmens HA
Vasa Suppl; 1989; 27():61-3. PubMed ID: 2623545
[No Abstract] [Full Text] [Related]
16. [Raynaud's phenomenon in the tongue of a patient with sclerodermia].
Klemp P; Staberg B; Thomsen K
Ugeskr Laeger; 1983 Jan; 145(5):333. PubMed ID: 6845496
[No Abstract] [Full Text] [Related]
17. Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis.
Sulli A; Soldano S; Pizzorni C; Montagna P; Secchi ME; Villaggio B; Seriolo B; Brizzolara R; Cutolo M
J Rheumatol; 2009 Jun; 36(6):1235-9. PubMed ID: 19369451
[TBL] [Abstract][Full Text] [Related]
18. [Decreased blood fluidity in progressive systemic scleroderma].
Ernst E; Lohmaier EF; Meurer M; Gerstmeier J
Z Rheumatol; 1990; 49(3):155-9. PubMed ID: 2378174
[TBL] [Abstract][Full Text] [Related]
19. Blood viscosity, plasma proteins, and Raynaud syndrome.
Tietjen GW; Chien S; Leroy EC; Gavras I; Gavras H; Gump FE
Arch Surg; 1975 Nov; 110(11):1343-6. PubMed ID: 53042
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
